Saturday 17 October 2026
Export AFMDQ’s income statement to Excel — free account
Affimed N.V.
AFMDQ Healthcare Biotechnology
Affimed N.V.’s revenue for fiscal 2023 (year ended December 2023) was $9.0 million, down 79.4% from fiscal 2022.
0.00
0.00
NaN
Follow AFMDQ
| Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | Jan '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
1 | 2 | — | 2 | — | 3 | — | 3 | — | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(10.41) | (1.17) | — | (1.70) | — | (1.87) | — | (2.80) | — | (1.90) |
P/S ratio |
10.43 | 0.40 | 14.14 | 1.38 | 1.56 | 1.50 | 0.71 | 0.73 | 0.70 | 0.67 |
Altman Z″-Score (non-manufacturers) |
(19.89) | (1.29) | — | (1.01) | — | (2.59) | — | (4.06) | — | (2.07) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.33 |
Beneish M-Score |
15.08 | (2.90) | — | (1.29) | — | (1.61) | — | (2.61) | — | 12.68 |
P/Operating CF |
(3.46) | (0.48) | (20.51) | (2.00) | 2.68 | 2.57 | 11.36 | 11.74 | 0.22 | 0.22 |
P/B ratio |
1.49 | 0.11 | 4.20 | 0.41 | 0.62 | 0.59 | 0.39 | 0.41 | 0.41 | 0.40 |
Price to Tangible BV |
1.49 | 0.11 | 4.25 | 0.42 | 0.63 | 0.61 | 0.39 | 0.41 | 0.41 | 0.40 |
EV/Sales |
3.09 | (3.78) | 9.68 | (3.08) | (3.61) | (3.67) | (4.05) | (4.02) | (3.69) | (3.71) |
EV/EBITDA |
0.00 | 1.83 | 0.00 | 1.98 | 3.04 | 3.10 | 2.75 | 2.73 | 4.57 | 4.60 |
EV/Operating CF |
(0.23) | 1.49 | (4.51) | 1.43 | 5.27 | 5.36 | 2.98 | 2.96 | (1.77) | (1.78) |
EV/FCF |
(0.22) | 1.46 | (4.32) | 1.37 | 5.15 | 5.24 | 2.84 | 2.82 | (1.80) | (1.81) |
Quick Ratio |
3.02 | 5.57 | 5.57 | 3.14 | 3.14 | 2.23 | 2.23 | 3.00 | 3.00 | 2.99 |
Current Ratio |
3.25 | 5.66 | 5.66 | 3.20 | 3.20 | 2.25 | 2.25 | 3.01 | 3.01 | 3.01 |
Net Debt/EBITDA |
0.58 | 2.03 | 2.02 | 2.87 | 2.69 | 4.36 | 4.56 | 3.23 | 3.19 | 5.44 |
Debt/Assets |
12.51% | 8.79% | 9.07% | 7.84% | 8.30% | 0.18% | 0.74% | 2.12% | 2.84% | 4.11% |
Debt/Equity |
0.21 | 0.12 | 0.12 | 0.13 | 0.14 | 0.00 | 0.02 | 0.06 | 0.08 | 0.12 |
Asset Turnover |
0.06 | 0.18 | 0.00 | 0.20 | 0.00 | 0.20 | 0.00 | 0.18 | 0.00 | 0.30 |
Operating CF/Net income |
1.04 | 1.22 | 1.22 | 1.51 | 1.51 | 0.47 | 0.47 | 0.90 | 0.90 | (2.54) |
Capex/Depreciation |
(2.13) | (0.24) | 0.00 | (2.89) | 0.00 | (0.39) | 0.00 | (1.63) | 0.00 | (1.79) |
| (102.52%) | (56.29%) | 0.00% | (55.99%) | 0.00% | (75.28%) | 0.00% | (79.93%) | 0.00% | (55.37%) | |
| (72.47%) | (37.94%) | 0.00% | (29.14%) | 0.00% | (28.94%) | 0.00% | (27.56%) | 0.00% | (24.74%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(167.66%) | (52.05%) | (51.08%) | (39.49%) | (40.77%) | (48.10%) | (44.33%) | (44.32%) | (43.70%) | (25.81%) |
Average Days of Receivables |
234.97 | 23.81 | 24.17 | 43.48 | 41.84 | 31.39 | 33.69 | 25.29 | 25.36 | 21.97 |
Research and Development Expense of Revenue |
1,147.53% | 238.95% | 232.57% | 201.87% | 199.25% | 176.27% | 173.32% | 204.72% | 201.33% | 148.09% |
Selling, General and Administrative Expense of Revenue |
298.19% | 77.56% | 76.94% | 60.00% | 59.31% | 48.36% | 47.37% | 47.99% | 47.15% | 40.61% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
129.48% | 46.21% | 0.00% | 29.28% | 0.00% | 11.92% | 0.00% | 11.54% | 0.00% | 8.57% |
Graham Net Nets |
0.52 | 9.08 | 0.21 | 2.10 | 1.06 | 1.11 | 2.12 | 2.05 | 2.11 | 2.19 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(122.47%) | (520.66%) | (10.01%) | (102.42%) | (95.71%) | (99.66%) | (200.00%) | (193.43%) | (121.12%) | (125.40%) |
Free Cash Flow Yield |
(134.26%) | (657.14%) | (15.85%) | (162.21%) | (44.80%) | (46.65%) | (200.85%) | (194.26%) | 295.28% | 305.72% |
Revenue per Share |
0.60 | 3.06 | 0.31 | 4.00 | 0.40 | 3.88 | 0.39 | 3.73 | 0.37 | 4.63 |
Operating CF per Share |
(7.99) | (7.76) | (0.77) | (8.57) | (0.86) | (2.65) | (0.26) | (5.07) | (0.51) | 9.65 |
Capex per Share |
(0.27) | (0.05) | 0.00 | (0.38) | 0.00 | (0.06) | 0.00 | (0.26) | 0.00 | (0.14) |
Free Cash Flow per Share |
(8.26) | (7.81) | (0.77) | (8.95) | (0.86) | (2.72) | (0.26) | (5.32) | (0.51) | 9.51 |
Cash per Share |
5.28 | 14.08 | 1.43 | 19.57 | 1.88 | 20.10 | 2.15 | 18.16 | 1.82 | 21.23 |
Shareholders Equity per Share |
4.19 | 11.32 | 1.15 | 13.46 | 1.29 | 9.85 | 1.06 | 6.74 | 0.68 | 7.83 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.19 | 11.32 | 1.15 | 13.46 | 1.29 | 9.85 | 1.06 | 6.74 | 0.68 | 7.83 |
Free Cash Flow |
(123.38) | (111.25) | (110.24) | (107.00) | (102.35) | (22.66) | (22.12) | (34.19) | (32.52) | 57.54 |
Working Capital |
63.08 | 170.07 | 172.27 | 167.82 | 161.31 | 95.69 | 102.50 | 79.22 | 79.40 | 87.44 |
Capital Expenditures |
(4.04) | (0.73) | (0.73) | (4.55) | (4.55) | (0.50) | (0.50) | (1.65) | (1.65) | (0.85) |
Net Current Asset Value |
48.53 | 156.43 | 158.46 | 138.67 | 133.29 | 53.76 | 57.59 | 36.09 | 36.17 | 41.14 |
EV/EBIT |
0.00 | 1.77 | 0.00 | 1.94 | 2.95 | 3.00 | 2.67 | 2.66 | 4.48 | 4.51 |
Capex to Sales |
0.45 | 0.02 | 0.00 | 0.10 | 0.00 | 0.02 | 0.00 | 0.07 | 0.00 | 0.03 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.36 | 0.76 | 0.65 | 0.35 | 0.29 | 0.50 | 0.33 | 0.40 | 0.29 | 0.29 |
Cash ROIC |
(79.80%) | (29.26%) | (28.58%) | (25.75%) | (25.55%) | (9.05%) | (8.21%) | (21.03%) | (19.85%) | 31.70% |
Accounts Receivable Turnover |
2.08 | 10.21 | 0.00 | 11.27 | 0.00 | 14.57 | 0.00 | 14.31 | 0.00 | 19.11 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
4.30 | 4.27 | 4.28 | 4.24 | 4.13 | 2.22 | 2.32 | 1.67 | 1.68 | 1.47 |
Average Payables |
20.29 | 21.21 | 20.08 | 17.66 | 16.22 | 12.49 | 10.86 | 11.54 | 11.32 | 7.93 |
Average Inventory |
0.58 | 0.58 | 0.58 | 0.39 | 0.38 | 0.31 | 0.32 | 0.32 | 0.32 | 0.29 |
Average Assets |
158.21 | 238.81 | 240.18 | 233.54 | 228.38 | 163.29 | 170.43 | 131.52 | 131.66 | 92.99 |
Average Common Equity |
111.84 | 160.98 | 162.02 | 121.54 | 118.42 | 62.77 | 65.70 | 45.35 | 45.40 | 41.54 |
Columns are period end dates